Similar safety results of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) from a phase III trial in patients (pts) with previously untreated advanced gastric cancer (AGC)

被引：0
|
作者：
Kang, Y. K.
Kang, W. K.
Shin, D. B.
Chen, J.
Xiong, J.
Wang, J.
Lichinitser, M.
Salas, M. P.
Suarez, T.
Santamaria, J.
机构：
[1] Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[2] Samsung Med Ctr, Dept Internal Med, Ilwon Dong, South Korea
[3] Gachon Med Sch, Gil Med Ctr, Dept Internal Med, Guwal Dong, South Korea
[4] Jiangsu Canc Hosp, Jiangsu, Peoples R China
[5] 1st Affiliated Hosp, Jianxi Med Coll, Jianxi, Peoples R China
[6] Shanghai Changzheng Hosp, Shanghai, Peoples R China
[7] Russian Canc Res Ctr, Blokhin Canc Res Ctr, Moscow, Russia
[8] Hosp Sabogal, Lima, Peru
[9] Ctr Med Pensiones, Yucatan, Mexico
[10] Inst Oncol Nacl, Ancon, Panama
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [41] Pharmacokinetics of liposomal cisplatin (lipoplatin) in combination with 5-FU in patients with advanced head and neck cancer:: First results of a phase III study
    Jehn, C. F.
    Boulikas, T.
    Kourvetaris, A.
    Possinger, K.
    Lueftner, D.
    ANTICANCER RESEARCH, 2007, 27 (1A) : 471 - 475
  • [42] Positive efficacy results of the X-ACT phase III trial of capecitabine (X) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with Dukes' C colon cancer
    McKendrick, Joseph
    Cassidy, James
    Van Hazel, Guy
    Twelves, Chris
    Wong, Alfred
    Nowacki, Marek
    Kroning, Hendrik
    Cervantes, Andres
    Herrmann, Richard
    Burris, Howard, III
    ANNALS OF ONCOLOGY, 2004, 15 : 73 - 74
  • [43] Epirubicin (E) in combination with cisplatin (CDDP) and capecitabine (C) versus docetaxel (D) combined with 5-fluorouracil (5-FU) by continuous infusion as front-line therapy in patients with advanced gastric cancer (AGC): Preliminary results of a randomized phase II trial of the Gruppo Oncologico Dell'Italia Meridionale
    Maiello, E.
    De Vita, F.
    Gebbia, V.
    Lorusso, V.
    Cinieri, S.
    Giuliani, F., Sr.
    Orditura, M.
    Fistola, E.
    Filippelli, G.
    Colucci, G., Sr.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [44] Results of a Phase I Trial of Induction Cisplatin, Docetaxel, 5-FU and Erlotinib followed by Cisplatin, Bevacizumab and Erlotinib with Radiotherapy for Advanced Head and Neck Cancer
    Ahn, P.
    Machtay, M.
    Anne, P. R.
    Wuthrick, E.
    Keane, W. M.
    Keane, W. M.
    Cognetti, D.
    Dicker, A. P.
    Axelrod, R. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S437 - S437
  • [45] Phase II trial of oxaliplatin, 5-FU, and leucovorin chemotherapy for the previously treated patients with advanced gastric cancer
    Oh, S. C.
    Kim, Y.
    Kim, J.
    Choi, I.
    Sung, H.
    Seo, H.
    Shin, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] A randomized phase II trial of weekly docetaxel plus either cisplatin or oxaliplatin in patients with previously untreated advanced gastric cancer: Preliminary results
    Sym, S.
    Park, S.
    Park, J.
    Park, Y.
    Jung, I.
    Cho, E.
    Lee, W.
    Chung, M.
    Shin, D.
    Lee, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 383 - 383
  • [47] Final results of a randomized phase III trial of docetaxel, carboplatin and 5FU versus epirubicin, cisplatin and 5FU for locally advanced gastric cancer
    Elsaid, AA
    Elkerm, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 311S - 311S
  • [48] A randomized phase II trial of weekly docetaxel plus either cisplatin or oxaliplatin in patients with previously untreated advanced gastric cancer: Preliminary results
    Sym, S.
    Park, S.
    Park, J.
    Kwon, K.
    Jung, I.
    Cho, E.
    Lee, W.
    Chung, M.
    Shin, D.
    Lee, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study
    Kim, Seung Tae
    Kang, Jung Hun
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Hwang, In Gyu
    Lee, Sang-Cheol
    Park, Keon-Woo
    Lee, Hyo Rak
    Kang, Won Ki
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (16) : 2822 - 2830
  • [50] EPIRUBICIN (E) IN COMBINATION WITH CISPLATIN (CDDP) AND CAPECITABINE (C) VERSUS DOCETAXEL (D) COMBINED WITH 5-FLUOROURACIL (5-FU) BY CONTINUOUS INFUSION (CI) AS FRONT-LINE THERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER (AGC): PRELIMINARY RESULTS OF A RANDOMISED PHASE II TRIAL OF THE GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE
    Silvestris, N.
    De Vita, F.
    Romano, M. P.
    Maiello, E.
    Gebbia, V.
    Lorusso, V.
    Cinieri, S.
    Giuliani, F.
    Orditura, M.
    Colucci, G.
    ANNALS OF ONCOLOGY, 2010, 21 : 227 - 227
12345